Raymond James Downgrades Abbott Labs (ABT) to Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. CHRW
9. AMD
10. RXO

Go back to Raymond James Downgrades Abbott Labs (ABT) to Market Perform

Abbott (ABT) Sees Q4 Sales Growth in Low-Mid Single-Digit Range

October 17, 2012 9:45 AM EDT

Abbott Laboratories (NYSE: ABT) said to see fourth-quarter sales growth in the low-to-mid single-digit range. Comments were made on the company's conference call this morning following... More

Abbott Laboratories (ABT) Tops Q3 EPS by 2c; Narrows FY12 EPS Outlook

October 17, 2012 7:45 AM EDT

Abbott Laboratories (NYSE: ABT) reported Q3 EPS of $1.30, $0.02 better than the analyst estimate of $1.28. Revenue for the quarter came in at $9.77 billion versus the consensus estimate of $9.93 billion.

Abbott Laboratories sees FY2012 EPS of $5.06-5.08, versus prior guidance of $5.00-5.10 and the consensus of $5.06.... More